论文信息 - A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC) - 字舞流文

A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC)

J. Dancey | E. Vokes | T. Karrison | E. Cohen | A. Mauer | M. Kozloff | Stuart J. Wong | A. Dekker | L. J. Skoog-Sluman